Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis.
Efficacy of
sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials.
Coseasonal
sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis.
Immune mechanisms of allergen-specific
sublingual immunotherapy.
Systematic reviews of
sublingual immunotherapy (SLIT).
9 patients who took the
sublingual immunotherapy tablets rather than placebo daily for 3 years, one additional patient experienced 'well days' for the entire grass pollen season during those 3 years, along with the next 2 years of no treatment.
Subcutaneous immunotherapy is clearly superior to
sublingual immunotherapy.
Nelson has just completed a review of 104 published studies of
sublingual immunotherapy, about half of which were double blind and placebo controlled.
HOUSTON --
Sublingual immunotherapy, or SLIT, long used by clinicians worldwide, is newly approved for use in the United States, and practice guidelines have yet to be published for U.
HOUSTON--Whether atopic dermatitis should be treated with allergen immunotherapy is still a matter of debate, as high-quality trial evidence remains scant, but clinical practice is starting to recognize the potential use of subcutaneous and
sublingual immunotherapy for certain presentations of the disease.
The safety of
sublingual immunotherapy with one or multiple pollen allergens in children.
Sublingual immunotherapy, widely used for allergy control and prevention in Europe and South America, is starting to draw the attention of mainstream allergists in the United States, Dr.
